Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
2022
Luzuriaga J, García-Gallastegui P, García-Urkia N, Pineda JR, Irastorza I, Fernandez-San-Argimiro F-J, Olalde B, Unda F, Madarieta I, Ibarretxe G. Osteogenic differentiation of human dental pulp stem cells in decellularised adipose tissue solid foams. Eur Cell Mater. 2022;43:112-129.
Ressler A, Antunović M, Teruel-Biosca L, Ferrer GGallego, Babić S, Urlić I, Ivanković M, Ivanković H. Osteogenic differentiation of human mesenchymal stem cells on substituted calcium phosphate/chitosan composite scaffold. Carbohydr Polym. 2022;277:118883.
Ma Y, Yang J, Hu Y, Xia Z, Cai K. Osteogenic differentiation of the MSCs on silk fibroin hydrogel loaded FeO@PAA NPs in static magnetic field environment. Colloids Surf B Biointerfaces. 2022;220:112947.
Liu Y, Wang J, Jiang M, Li X, Zhang Q, He H. Osteoinductive hybrid hydrogel membranes for in situ bone regeneration in hyperglycemia. Colloids Surf B Biointerfaces. 2022;214:112450.
Kuhlen M, Kunstreich M, Gökbuget N, Escherich G. [Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia]. Orthopadie (Heidelb). 2022.
Huybrechts Y, Van Hul W. Osteopetrosis associated with PLEKHM1 and SNX10 genes, both involved in osteoclast vesicular trafficking. Bone. 2022:116520.
Zhou J, Chen X, Zhou P, Sun X, Chen Y, Li M, Chu Y, Zhou J, Hu X, Luo Y, et al. Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia. Biochem Biophys Res Commun. 2022;600:29-34.
Self C, MacQuarrie KL, Cost CR. Osteosarcoma/Ewing Sarcoma. Pediatr Rev. 2022;43(5):256-265.
Zhang X-R, OuYang Y-C, Meng T-G, Zhang H-Y, Yue W, Yan F-Z, Xue Y, Schatten H, Wang Z-B, Sun Q-Y. OTSSP167 leads to follicular dysplasia and negatively affects oocyte quality in mice. Toxicology. 2022:153243.
Cheng Q, Wang D, Lai X, Liu Y, Zuo Y, Zhang W, Lei L, Chen J, Liu H, Wang Y, et al. The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease. Blood. 2022.
Yang T-T, Song X-L, Zhao Y-M, Ye B-D, Luo Y, Xiao H-W, Chen Y, Fu H-R, Yu J, Liu L-Z, et al. Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients. Ann Hematol. 2022.
Groenendijk A, van Tinteren H, Jiang Y, de Krijger RR, Vujanic GM, Godzinski J, Rübe C, Schenk J-P, Morosi C, Pritchard-Jones K, et al. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols. Eur J Cancer. 2022;163:88-97.
Itonaga H, Kida M, Hamamura A, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Kataoka K, Katayama Y, Ota S, et al. Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis. Hematol Oncol. 2022.
Gehlsen U, Faust C, Blecha C, Dietrich-Ntoukas T, Eberwein P, Issleib S, Meyer-Ter-Vehn T, Braun R, Westekemper H, Steven P. Outcomes and complications of cataract surgery in patients with chronic ocular graft-versus-host-disease-a multicenter, retrospective analysis. Graefes Arch Clin Exp Ophthalmol. 2022.
Manjappachar NK, Cuenca JA, Ramírez CM, Hernandez M, Martin P, Reyes MP, Heatter AJ, Gutierrez C, Rathi N, Sprung CL, et al. Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria. J Natl Compr Canc Netw. 2022;20(1):45-53.
Li B, Meng L, Tian Y, Lu Q, Gao L, Xiao P, Lu J, Li J, Wan L, Li Z, et al. Outcomes and risk factors of hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplantation recipients using different graft source and condition with severe aplastic anemia. Hematology. 2022;27(1):714-722.
Winters AC, Bosma G, Abbott D, Minhajuddin M, Jordan C, Pollyea DA, Gutman JA. Outcomes Are Similar Following Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy. Transplant Cell Ther. 2022.
Ros-Soto J, Snowden JA, Szydlo R, Nicholson E, Madrigal A, Easdale S, Potter M, Ethell M, Anthias C. Outcomes following DLI in patients with haematological malignancies: Donor characteristics matter. Transplant Cell Ther. 2022.
Desai AV, Gilman AL, Ozkaynak MFevzi, Naranjo A, London WB, Tenney SC, Diccianni M, Hank JA, Parisi MT, Shulkin BL, et al. Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group. J Clin Oncol. 2022:JCO2102478.
Shields AM, Anantharachagan A, Arumugakani G, Baker K, Bahal S, Baxendale H, Bermingham W, Bhole M, Boules E, Bright P, et al. Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK. Clin Exp Immunol. 2022.
Schultz KAnn P, Harris AK, Nelson AT, Watson D, Lucas JT, Miniati D, Stewart DR, Hagedorn KN, Mize W, Kamihara J, et al. Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/ Registry. J Clin Oncol. 2022:JCO2102925.
Yi JHo, Jeong SHyun, Kim SJin, Yoon DHyun, Kang HJin, Koh Y, Kim JSeok, Lee W-S, Yang D-H, Do YRok, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer Res Treat. 2022.
Murthy HS, Ahn KWoo, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, et al. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2022.
Munshi PN, Chen Y, Ahn KW, Awan FT, Cashen A, Shouse G, Shadman M, Shaughnessy P, Zurko J, Locke FL, et al. Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B Cell Lymphoma. Transplant Cell Ther. 2022.
Attarbaschi A, Möricke A, Harrison CJ, Mann G, Baruchel A, de Moerloose B, Conter V, Devidas M, Elitzur S, Escherich G, et al. Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/ Rearrangements in a Modern Therapy Era: A Retrospective International Study. J Clin Oncol. 2022:JCO2201297.

Pages